Industry News

LISI Group has achieved sales of €342.4 million in Q1 2022, up 10.7% compared to 2021. All three divisions of the Group finished up compared to the same period of the previous year, with LISI AEROSPACE up 20.5%, LISI AUTOMOTIVE up 0.6% and LISI MEDICAL up 12%.

LISI AEROSPACE’s sales amounted to €167.9 million at the end of March 2022. Sales for Q1 2022 in the ‘Fasteners’ business in Europe increased by +12.5%, confirming the return to growth initiated in Q4 2021 (+4.8%). The ‘Fasteners’ business in the United States saw the strongest growth over the quarter (+28.7%).

The ‘Structural Components’ business maintained the good momentum initiated at the start of the 2021 financial year. It benefited from the anticipated needs for basic parts intended for long cycle equipment (engines) to meet the increase in production rates among aircraft manufacturers, as well as for those intended for maintenance. The segment’s sales for the quarter were thus up 19.2% compared to the same period in 2021.

In a market where there was an -8.3% decline in the worldwide production over the entire ecosystem in Q1 2022, LISI AUTOMOTIVE’s sales (€141.1 million) increased by 0.6% compared to the same period in the previous year. The division once again confirms its ability to gain market share. This mainly concerns new products that meet the growing needs in terms of electromobility (powertrain and related functions).

Finally, LISI MEDICAL’s sales amounted to €33.4 million at the end of March 2022, up 12% compared to the same period in the previous financial year, confirming the improvement trend observed in Q4 2021 (+19.3% compared to the last quarter of 2020). Sales growth is driven by market share gains for new products developed over the past four years and by increased volumes for flagship products.